Inhibitex - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Inhibitex M&A Summary

Inhibitex has acquired 1 company of its own.

Inhibitex has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Inhibitex Ownership

Who owns Inhibitex?

Inhibitex is owned by Bristol-Myers Squibb. It was acquired on January 7, 2012.

Inhibitex Business Overview

Where is Inhibitex headquartered?

Inhibitex is headquartered in Alpharetta, Georgia.

How many employees does Inhibitex have?

Inhibitex has 33 employees.

What sector is Inhibitex in?

Inhibitex is a life science company.

When was Inhibitex founded?

Inhibitex was founded in 1994.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Inhibitex, Inc.

9005 Westside Parkway,
Alpharetta, Georgia 30009
United States,
(678)746-1100
www.inhibitex.com

Inhibitex, Inc. is a biopharmaceutical company focused on developing products to prevent and treat serious infectious diseases. The Company’s clinical-stage pipeline includes three Phase 2 development programs: INX-189, a nucleotide polymerase inhibitor in development for the treatment of chronic hepatitis C infections, FV-100, a nucleoside inhibitor in development for the reduction of shingles-associated pain, and Aurexis, a humanized monoclonal antibody in development for the treatment of serious S. aureus bloodstream infections.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
FermaVir Pharmaceuticals, Inc. 2007-04-10 - Add-on Acquisition
New York, New York · www.fermavir.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - - -
Total 1 - - -

By Geo

State/Country Buy Value Sell Value
United States 1 - - -
  New York 1 - - -
Total 1 - - -

 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.